Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Intera ...

Purpose: Failure mode and effects analysis (FMEA) was used to evaluate a smart i.v. pump as it was implemented into a redesigned medication-use process. Summary: A multidisciplinary team conducted ...

Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain ... us to provide a more comprehensive set of solutions to physicians and their ...

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology ... us to provide a more comprehensive set of solutions to physicians and their patients ...

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software ...

NOPAIN mandates separate payment for qualified treatments through Dec. 31, 2027, when provided with a covered surgical procedure. Avanos says this makes its infusion systems the first and only pain ...

With more than 325,000 pumps installed worldwide, the Plum A+™ general purpose infusion system remains ... Deliver secondary infusions via IV container or syringe ...

They will attach the IV line to the bag of medicine, hooked to a pump, and the fluid will slowly enter your body over a set period of time. During the infusion, you can pass the time in the chair ...

Connor Clark & Lunn Investment Management Ltd. lifted its position in shares of Iradimed Corporation (NASDAQ:IRMD – Free ...

Although the 2015 Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical ...